Le Lézard6h
U.S. FDA Approves Expanded Label for Astellas' IZERVAYtm (avacincaptad pegol intravitreal solution) for Geographic Atrophy
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAYtm ...
Healio10h
Patient selection for premium IOLs requires corneal diagnostics
Ophthalmologists must embrace corneal diagnostics to select the proper patient for premium multifocal IOLs, according to a ...
Bloomberg L.P.15h
National Vision Holdings Inc
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...